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Abstract
Background and aims. Chronic pancreatitis develops in 510% of alcohol addicts. In developed societies, alcohol is the cause
of chronic pancreatitis in at least 7080% of cases. The genetic polymorphism of enzymes involved in alcohol metabolism is
relevant in the etiopathogenesis of chronic pancreatitis. The aim of the study was to find the ADH, ALDH2 and CYP2E1
alleles and genotypes in the Polish population that are likely to be responsible for higher susceptibility to chronic alcohol
pancreatitis. Material and methods. We determined the allele and genotype of ADH2, ADH3, ALDH2 and CYP2E1 in 141
subjects: 44 with alcohol chronic pancreatitis (ACP), 43 healthy alcoholics and 54 healthy non-drinkers as the controls.
Genotyping was performed using PCR-RELP methods on white cell DNA. Results. ADH2*1, ADH3*1 alleles and
ADH2*1/*1, ADH3*1/*1 genotypes were statistically more frequent among the patients with ACP than among the controls.
The ADH3*2/*2 genotype was more frequent among ‘‘healthy alcoholics’’ and in the controls than among those with ACP.
In the studied group, only the ALDH2*1 allele was detected, all patients were ALDH2*1/*1 homozygotic. Differences in
the CYP2E1 allele and genotype distribution in the examined groups were not significant. Conclusion. In the Polish
population examined, ADH3*1 and ADH2*1 alleles may be risk factors for the development of alcoholism. The ADH3*2/
*2 genotype may confer protection against ACP. CYP2E1 gene polymorphism is not related to alcoholism and ACP. The
Polish population examined is ALDH2*1/*1 homozygotic.
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Introduction
The abuse of alcohol leads to injury to many organs:
the liver, pancreas, gastric mucous membrane and
cerebral tissue, and results in the loss of behavior
control. In Poland, people treated for alcohol depen-
dency account for about 3% of the population [1].
Chronic pancreatitis develops in 510% of alcohol
addicts [2], and in developed societies alcohol is the
cause of chronic pancreatitis in at least 7080% of
cases [3,4]. Genetic factors are important in the
susceptibility to pancreatic injury, severity and evolu-
tion of inflammatory processes leading to chronic
inflammation or fibrosis. Discovery of the gain of
function mutations of pancreatic secretory trypsin
inhibitor (SPINK 1) or other potential defects in
genes that regulate pancreatic secretory function, or
modulate inflammatory response to pancreatic injury
(TNF, IL-1, IL-10 genes), has changed the current
concept concerning the pathogenesis of pancreatitis.
Some few studies indicate that mutations of the
cationic trypsinogen gene (PRSS1), cystic fibrosis
transmembrane conductance regulator gene (CFTR)
and SPINK may also be risk factors for the developing
alcohol chronic pancreatitis (ACP) [57].
It is known that genetic polymorphism of the
enzymes involved in alcohol metabolism has a relevant
role in the etiopathogenesis of alcohol liver disease.
Several genes encoding ethanol metabolizing enzymes
have been proposed and studied in recent years,
among them alcohol dehydrogenase (ADH), aldehyde
dehydrogenase (ALDH), cytochrome P-4502E1-
CYP2E1, glutathione S-transferase M1-GSTM1,
GSTT1, with controversial or inconclusive results in
people of different races with ACP. It is assumed that
this is associated with genetically determined differ-
ences in alcohol metabolism. Polymorphic genes
ADH1B and ADH1C code different forms of b and
g subunits of different features each. The ADH1B
gene occurs in the form of three alleles, ADH2*1,
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ADH2*2 and ADH2*3 responsible for b1, b2 and b3
subunit coding [8,9]. The ADH2*1 and ADH2*2
alleles occur among Caucasians and Asians, ADH2*3
in 25% of the Afro-American population [10], i.e.
relatively more often than among the white American,
European and Chinese populations [11]. The b1
subunit is barely active in the metabolism of alcohol,
while b2 is highly active in this respect.
The ADH3 gene gives two alleles, ADH3*1 and
ADH3*2, which code respective subunits g1 of higher
activity and g2 of lower activity towards ethanol [8,9].
The ALDH2 izoenzyme is the main form of
aldehyde dehydrogenase responsible for acetate alde-
hyde oxidation. The ALDH2 gene has two alleles,
ALDH2*1 and ALDH2*2, the latter predominant
and typical of Asians and North American Indians
and does not occur in Caucasians [12].
Between 10% and 15% of ethanol consumed is
metabolized by MEOS [2]. The activity of this system
increases as a consequence of long-term ethanol
abuse. Alcohol metabolism in individuals who drink
regularly causes 510 times higher stimulation of
MEOS than in individuals who do not drink abso-
lutely or drink sporadically. ADH alcohol oxidation
takes place mainly at lower alcohol concentrations in
blood, while the peak action of MEOS is observed at
high concentrations [8]. The most important enzyme
of this metabolic pathway is cytochrome P-450
CYP2E1. The CYP2E1 gene exhibits polymorphism
in the 5‘ flanking region of human cytochrome
CYP2E1. The CYP2E1 gene forms two alleles  c1
and c2 [13]. The CYP2E1 genetic polymorphism
varies significantly among different ethnic groups
[14].
The aim of the study was to find the ADH2,
ADH3, ALDH2 and CYP2E1 alleles and genotypes
in the Polish population that are likely to be respon-
sible for the higher susceptibility to ACP. We studied
the frequency of alleles for the ADH2, ADH3,
ALDH2 and CYP2E1 genotype in the Polish popula-
tion when comparing patients with ACP, patients
addicted but without pancreas damage or non-drin-
kers.
Material and methods
Subjects
The study comprised 141 subjects (30 F and 111 M;
average age 45.299.4 years). The patient group with
chronic alcohol abuse included 44 with ACP and 43
alcoholics with no damage to gastrointestinal organs,
the pancreas in particular, considered as healthy
alcoholics. Fifty-four healthy volunteers, total abstai-
ners, formed a control group.
The chronic alcohol abusers group included pa-
tients consuming on average over 80 g of pure ethanol
a day over at least 2 years, average 160.9943.9 g
daily. Alcohol history was obtained during a face-to
face interview.
All the drinkers examined had a positive CAGE
screening test [15] and the patients of the alcoholics
group met the DSM-IV diagnostic criteria for alco-
holism [16]. They were recruited from the Depart-
ment of Gastroenterology and from the Department
of Therapy of Addiction to Alcohol.
The diagnosis of chronic pancreatitis was based on
the generally accepted criteria: medical history, phy-
sical examination, abdominal X-ray picture, ultra-
sound, CT of the abdominal cavity, ERCP and
pancreatic exocrine function tests [17]. Twenty-seven
patients had ERCP confirming the diagnosis of
chronic pancreatitis. In the remaining 27 patients,
abdominal X-ray, ultrasound and CT confirmed the
diagnosis sufficiently. Calcifications in the area of the
pancreas were shown in abdominal X-ray. Ultrasound
and CT demonstrated atrophy or diffuse calcification
of the pancreas, irregularity and dilated extension of
the main pancreatic duct. The alcoholic etiology was
defined on the basis of the history.
The alcoholics group underwent examinations to
exclude alimentary pathology, particularly of the liver
and pancreas. Results of the examinations indicated
no organ damage.
The control group comprised healthy volunteers
whose histories revealed no consumption of alcohol.
Diagnostic tests were performed to exclude any
digestive pathology.
All the patients in this study were recruited from the
same city and were homogeneity ethnic of the
Caucasian race group. The study was approved by a
local ethics committee and all subjects gave informed
consent for examinations.
Genomic DNA and oligonucleotide
Genomic DNA was isolated from 15 mL of peripheral
blood [18].
Genotyping of ADH2 gene polymorphism
For detection of polymorphism in the ADH2 gene,
the polymerase chain reaction restriction fragment
length polymorphism (PCR-RFLP) technique was
used on white cell DNA. The primers for amplifica-
tion were the following: ADH2 247, ADH2 303 and
ADH2 290, ADH2 424 and ADH2 352. The ampli-
fied product was digested with MaeIII enzyme (Roche
Applied Science) and with AluI enzyme (MBI Fer-
mantas) and subjected to electrophoresis in 12%
polyacrylamide gel stained with silver nitrate [19].
Genotyping of ADH3 gene polymorphism
Detection of polymorphisms in the ADH3 gene was
performed using polymerase chain reactionrestric-
tion fragment length polymorphism (PCR-RFLP).
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The primers for amplification were: ADH3 321 and
ADH3 351. The amplified product was digested with
the SspI enzyme (MBI Fermantas) subjected to
electrophoresis in 3% agarose gel, stained with
ethidium bromide [19].
Genotyping of ALDH2 gene polymorphism
Polymorphisms in the ALDH2 gene were detected
using the polymerase chain reactionrestriction frag-
ment length polymorphism (PCR-RFLP) method.
The primers for amplification were ALDH2 YC1
and ALDH2 YC2. The amplified product was di-
gested with EcoRI enzyme (MBI Fermantas) and
subjected to electrophoresis in 12% polyacrylamide
gel stained with silver nitrate [20].
Genotyping of CYP2E1 gene polymorphism
Detection of polymorphisms in the 5?-flanking region
of the P4502E1 gene was performed using polymerase
chain reactionrestriction fragment length poly-
morphism (PCR-RFLP). The primers for amplifica-
tion were: CYP2E J8 and CYP2E J9. The amplified
product was digested with PstI or RsaI enzyme (MBI
Fermantas) and subjected to electrophoresis in 2%
agarose gel, stained with ethidium bromide [13].
Statistical analysis
The allele and genotype frequencies between the
examined groups were compared using the x2 test of
association. In the event of too few data, the results
were corrected by Yates. PB0.05 was considered to be
statistically significant. The calculations were per-
formed using the computer statistical program STA-
TISTICA PL [21].
Results
ADH2*1 allele frequencies were 100% in patients
with alcohol chronic pancreatitis and 94.44% in the
controls. The tests found no ADH2*3 allele in
examined groups. ADH3*1 allele frequency was
68.18% and 40.74%, respectively. Genotype number
and allele frequencies of ADH2 and ADH3 in the
groups examined are presented in Tables I and II.
ADH2*1 and ADH3*1 alleles were statistically
more frequent among the patients with ACP in
comparison to the controls (pB0.05 and pB0.001,
respectively). In the group of patients who abused
alcohol, the differences were not statistically signifi-
cant (p0.05). The ADH2*2 allele was not detected
in ACP patients.
In the population examined, the ADH2*1/*1 gen-
otype was determined in 134 individuals, and the
ADH2*1/*2 genotype was detected in 7 patients. The
ADH2*2/*2 genotype was not found at all.
In no patient with ACP was the ADH2*1/*2
genotype presented. All were ADH2*1/*1 homozygo-
tic. The ADH2*1/*1 and ADH3*1/*1 genotypes were
statistically more frequent among the patients with
alcohol pancreatitis than among the controls (pB0.05
and pB0.001, respectively), but the difference was
not statistically significant between the ACP group
and alcoholics (p0.05). Comparison of ADH3*2/*2
genotype frequency in the studied groups showed that
it was statistically significantly rarer among patients
with ACP than among alcoholics and controls.
In the study group, only the ALDH2*1 allele was
detected, all patients were ALDH2*1/*1 homozygo-
tic.
In the examined population, all of which abused
alcohol, the c2 allele frequency was 0.71% (Table III).
In the group of patients with ACP, it was 2.27%. The
c2/c2 genotype was not found in any patient. The
genotype c1/c1 occurred in 139 patients, and hetero-
zygotes c1/c2 were present in only 2 patients (with
ACP). The c1/c2 genotype was not demonstrated in
alcoholics. Differences in the allele and genotype
distribution in the examined groups were not signifi-
cant.
Discussion
Genetic polymorphism of the enzymes involved in
alcohol metabolism is relevant in the etiopathogenesis
of ACP. It is highly ethnically and race dependent.
The ADH2*2 allele is decisively more common
among Asians (60% to 80%) than among the white
population (0% to 10%) [22]. The ADH2*2 allele is
1.32 times more frequent among the non-drinkers
than among patients who abuse alcohol [2325].
Table I. Genotype number and allele frequencies (%) of ADH2 in the groups examined.
Genotype Allele
Patient group n *1/*1 *1/*2 *2/*2 *1 *2
Chronic alcohol pancreatitis 44 44* NS 0* NS 0 100* NS 0* NS
Healthy alcoholics 43 42 1 0 98.84 1.16
Control 54 48 6 0 94.44 5.56
Total 141 134 7 0 97.52 2.48
*pB0.05 versus control group.
NSNon-significant difference versus healthy alcoholics.
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In our study, ADH2*1 alleles occurred statistically
significantly more frequently among the ACP patients
than among the controls, but the differences between
the groups of patients who abused alcohol were not
statistically significant. So, they favor developing
alcohol consumption but not necessarily developing
ACP. On the other hand, ADH2*2 alleles predomi-
nated among non-drinkers. The ADH2*2 allele may
thus be a protector against alcoholism only. In other
studies, however, the role for the ADH2 polymorph-
ism has been found in ACP [26,27].
The role of alcohol-metabolizing enzyme gene
polymorphisms is controversial and not clear. There
are a few reports in the literature discussing the
relationship between ACP and ADH3 genetic poly-
morphism. Chronic alcohol pancreatitis was more
common in ADH3*1 and ADH3*2 homozygotes
than heterozygotes. Heterozygotic alleles seem to be
protective in the etiology of chronic pancreatitis [28].
Our results were different. In the group with ACP the
most common was the heterozygotic ADH3*1/*2
genotype; however, 2.3% were homozygotic
ADH3*2/*2 genotype. Thus, presence of the
ADH1C*2/*2 genotype generally does not favor
alcoholism and may protect against ACP. On the
other hand, ADH3*1 alleles were markedly concomi-
tant with chronic pancreatitis of alcoholic etiology and
healthy alcoholics. Day et al. [8] and Dumas et al.
[29] suggested a relationship between the ADH3*1
allele and ACP, although there are studies of Cauca-
sian and Japanese populations in which no relation-
ship was found between ADH3 polymorphism and
pancreatitis [27,3033].
Frequency of the ALDH2 alleles varies among
populations. The ALDH2*2 allele occurs mainly in
oriental populations, i.e. Japanese, Chinese, inhabi-
tants of Taiwan and Korea, and protects against
developing alcoholism and alcohol liver disease
[20,3437]. Its role in alcohol pancreatitis was not
evaluated. Investigations of the Caucasian race have
found an almost totally homozygotic character of
ALDH2*1 [9,22,38]. Our observation here is similar.
No variations in ALDH alleles or genotypes were
found. In the studied group, none of the patients
examined presented the ALDH2*2 allele. All were
homozygotic ALDH2*1/*1, so we could not examine
correlations between ALDH2 gene polymorphism
and ACP.
The role of genetic polymorphism of CYP2E1 in
ACP is poorly defined and remains unclear. In our
study, the c2 allele frequency was 2.27% of patients
with ACP. In the group of Italian patients with ACP its
prevalence was 2.3% [39], as in our study. Such a rare
presence of this allele in the above-mentioned group of
patients did not allow us to draw explicit conclusions.
We did not found relations between this disease and
CYP2E1 polymorphism. Similarly, results published
by other authors do not support the hypothesis of
correlation between the c2 allele and ACP [26,27].
Yang et al. [40] and Verlaan et al. [41] studying the
Caucasian population did not demonstrate statistically
significant differences in the presence of the c2 allele
among patients with ACP, idiopathic pancreatitis,
healthy alcoholics and controls.
Studies concerning the role of the glutathione
S-transferase gene in development of ACP show that
the GSTM1 null genotype seems to protect a subset
Table II. Genotype number and allele frequencies (%) of ADH3 in the groups examined.
Genotype Allele
Patient group n *1/*1 *1/*2 *2/*2 *1 *2
Chronic alcohol pancreatitis 44 17* NS 26# NS 1* ** 68.18* NS 31.82* NS
Healthy alcoholics 43 17 17 9 59.30 40.70
Control 54 10 24 20 40.74 59.26
Total 141 44 67 30 54.96 45.04
*pB0.001 versus control.
**pB0.001 versus healthy alcoholics.
NSNon-significant difference versus healthy alcoholics.
#NSNon-significant difference versus healthy alcoholics and versus control.
Table III. Genotype number and allele frequencies (%) of CYP2E1 in the groups examined.
Genotype Allele
Patient group n c1/c1 c1/c2 c2/c2 c1 c2
Chronic alcohol pancreatitis 44 42 2 0 97.73 2.27
Healthy alcoholics 43 43 0 0 100 0
Control 54 54 0 0 100 0
Total 141 139 2 0 99.29 0.71
Differences in genotype number and allele frequencies between the groups defined were not significant.
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of subjects (women under age of 50 years) from this
disease [42].
In conclusion, our analysis and studies presented
suggest that the ADH3*1 and ADH2*1 alleles may be
risk factors for developing alcoholism. The ADH3*2/
*2 genotype may confer protection against ACP.
CYP2E1 gene polymorphism is not related to alco-
holism and ACP. The Polish population examined is
ALDH2*1/*1 homozygotic.
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